Anthony Rosenberg's most recent trade in Cullinan Oncology Inc was a trade of 38,513 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cullinan Oncology Inc | Anthony Rosenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 38,513 | 38,513 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Anthony Rosenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 15,806 | 15,806 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Anthony Rosenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,450 | 18,450 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Anthony Rosenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,475 | 16,475 | - | - | Stock Option (Right to Buy) |